November 14, 2023

This is an exciting time for heart health as a recent landmark study called SELECT has shown that taking the anti-obesity medication semaglutide can lower your risk for having a second cardiac event by 20%, while losing an average of over 9% body weight. And a new American Heart Association (AHA) Presidential Advisory highlights the